A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function

Author: Derosa Giuseppe   Carbone Anna   D'Angelo Angela   Querci Fabrizio   Fogari Elena   Cicero Arrigo FG   Maffioli Pamela  

Publisher: Informa Healthcare

ISSN: 1465-6566

Source: Expert Opinion on Pharmacotherapy, Vol.13, Iss.17, 2012-12, pp. : 2433-2442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content